Elias Lolis, PhD

Professor of Pharmacology; Director of Graduate Studies

Departments & Organizations

Pharmacology: Lolis Lab | Primary Faculty

Cancer Center: Developmental Therapeutics

Faculty Research

Structural Biology

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Biochemistry, Biophysics and Structural Biology: Cell Cycle and Signal Transduction; Membrane Biology and Motion | Computational Biology and Bioinformatics: Computational Analysis of Macromolecular Structures | Molecular Medicine, Pharmacology, and Physiology: Cancer Biology and Therapeutics; Receptors and Signal Transduction; Structural Biology

Office of Cooperative Research


Elias Lolis received his PhD in 1989 from MIT in Chemistry/Biochemistry studying the three-dimensional structure and mechanism of triosephosphate isomerase. He was a postdoctoral associate at the Laboratory of Medical Biochemistry at Rockefeller University studying the functional interaction between advanced glycation end products (AGEs) and the immune system. He joined the Yale faculty in 1991 as an Assistant Professor focusing on the structure, mechanism, and inhibition of chemokines, macrophage migration inhibitory factor (MIF), and their receptors. He has received a Pharmaceutical Manufacturers Association Faculty Development Award in Basic Pharmacology, the Donaghue Young Investigator Award, the GlaxoWellcome Award in Drug Discovery.

Education & Training

PhD Massachusetts Institute of Technology (1989)
BA Columbia College (1984)
Postdoc Laboratory of Medical Biochemistry

International Activity

  • PhD reviewer Lausanne, Switzerland (2010 - 2010)

    Outside reviewer of two PhDs

  • Review of project program Dublin, Ireland (2006 - 2006)

    Site visit reviewer for the Scientific Foundation of Ireland

Edit this profile